Insider Trading Alert - WCG, TRS, RDN, THC And IVZ Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 14, 2013, 154 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $292.50 to $467,462,888.00.

Highlighted Stocks Traded by Insiders:

WellCare Health Plans (WCG) - FREE Research Report

Cunningham Alexander R. who is Director at WellCare Health Plans sold 54,305 shares at $67.27 on Nov. 14, 2013. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 54,305 share transaction.

The shares most recently traded at $69.08, up $1.81, or 2.62% since the insider transaction.

The average volume for WellCare Health Plans has been 513,500 shares per day over the past 30 days. WellCare Health Plans has a market cap of $2.9 billion and is part of the health care sector and health services industry. Shares are up 38.57% year to date as of the close of trading on Thursday.

WellCare Health Plans, Inc. provides managed care services for government-sponsored health care programs in the United States. The company has a P/E ratio of 16.4. Currently there are 5 analysts that rate WellCare Health Plans a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WCG - FREE

TheStreet Quant Ratings rates WellCare Health Plans as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full WellCare Health Plans Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

TriMas Corporation (TRS) - FREE Research Report

Tredwell Daniel P who is Director at TriMas Corporation sold 91,100 shares at $37.71 on Nov. 14, 2013. Following this transaction, the Director owned 1.0 million shares meaning that the stake was reduced by 8.18% with the 91,100 share transaction.

The shares most recently traded at $37.33, down $0.38, or 1.01% since the insider transaction. Historical insider transactions for TriMas Corporation go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 100
  • 12-Week # shares sold: 7,000
  • 24-Week # shares bought: 100
  • 24-Week # shares sold: 60,500

The average volume for TriMas Corporation has been 302,300 shares per day over the past 30 days. TriMas Corporation has a market cap of $1.7 billion and is part of the industrial goods sector and industrial industry. Shares are up 34.75% year to date as of the close of trading on Thursday.

TriMas Corporation designs, manufactures, and distributes various products for commercial, industrial, and consumer markets worldwide. The company has a P/E ratio of 28.8. Currently there are 5 analysts that rate TriMas Corporation a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on TRS - FREE

TheStreet Quant Ratings rates TriMas Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full TriMas Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Radian Group (RDN) - FREE Research Report

Wender Herbert who is Director at Radian Group bought 5,000 shares at $12.68 on Nov. 14, 2013. Following this transaction, the Director owned 182,670 shares meaning that the stake was reduced by 2.81% with the 5,000 share transaction.

Ibrahim Sanford A who is Chief Executive Officer at Radian Group bought 5,000 shares at $12.63 on Nov. 14, 2013. Following this transaction, the Chief Executive Officer owned 177,829 shares meaning that the stake was reduced by 2.89% with the 5,000 share transaction.

The shares most recently traded at $13.26, up $0.63, or 4.76% since the insider transaction.

The average volume for Radian Group has been 4.5 million shares per day over the past 30 days. Radian Group has a market cap of $2.2 billion and is part of the financial sector and insurance industry. Shares are up 108.02% year to date as of the close of trading on Thursday.

Radian Group Inc., through its subsidiaries, operates as a credit enhancement company in the United States. The company operates in two segments, Mortgage Insurance and Financial Guaranty. The stock currently has a dividend yield of 0.08%. Currently there are 4 analysts that rate Radian Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on RDN - FREE

TheStreet Quant Ratings rates Radian Group as a hold. Among the primary strengths of the company is its solid stock price performance. At the same time, however, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Radian Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Tenet Healthcare (THC) - FREE Research Report

Glenview Capital Management, Llc who is 10% Owner at Tenet Healthcare sold 80,000 shares at $43.77 on Nov. 14, 2013. Following this transaction, the 10% Owner owned 9.9 million shares meaning that the stake was reduced by 0.8% with the 80,000 share transaction.

The shares most recently traded at $42.42, down $1.35, or 3.18% since the insider transaction. Historical insider transactions for Tenet Healthcare go as follows:

  • 4-Week # shares bought: 12,500
  • 12-Week # shares bought: 12,500
  • 12-Week # shares sold: 24,873
  • 24-Week # shares bought: 12,500
  • 24-Week # shares sold: 24,873

The average volume for Tenet Healthcare has been 1.8 million shares per day over the past 30 days. Tenet Healthcare has a market cap of $4.3 billion and is part of the health care sector and health services industry. Shares are up 33.51% year to date as of the close of trading on Thursday.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Currently there are 8 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on THC - FREE

TheStreet Quant Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share and revenue growth. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Tenet Healthcare Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Invesco (IVZ) - FREE Research Report

Meadows Colin who is Senior Managing Director at Invesco sold 35,000 shares at $33.38 on Nov. 14, 2013. Following this transaction, the Senior Managing Director owned 385,086 shares meaning that the stake was reduced by 8.33% with the 35,000 share transaction.

The shares most recently traded at $33.82, up $0.44, or 1.3% since the insider transaction. Historical insider transactions for Invesco go as follows:

  • 4-Week # shares sold: 200,000
  • 12-Week # shares sold: 200,000
  • 24-Week # shares sold: 200,000

The average volume for Invesco has been 4.0 million shares per day over the past 30 days. Invesco has a market cap of $14.8 billion and is part of the financial sector and financial services industry. Shares are up 27.56% year to date as of the close of trading on Thursday.

Invesco Ltd. is a publicly owned investment manager. It primarily provides its services to institutional clients including major public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, and financial institutions. The stock currently has a dividend yield of 2.7%. The company has a P/E ratio of 18.2. Currently there are 8 analysts that rate Invesco a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IVZ - FREE

TheStreet Quant Ratings rates Invesco as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Invesco Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home